Answer
Rufinamide 800 mg twice daily for 14 days reduced mean ethinylestradiol exposure by 22% and norethindrone exposure by 14% with a studied combined oral contraceptive; women of childbearing potential using hormonal contraception should use an additional safe and effective contraceptive method.
Sources for this answer
- Rufinamide Eisai 100mg TabletsEisai Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 22Document updated
Sources checked